Genome-wwide analysis of histone H3 lysine 4 trimethylation in peripheral blood mononuclear cells of minimal change nephrotic syndrome patients

American Journal of Nephrology

Volumn 30, Issue 6, 2009, Pages 505-513

  Zhang, Li ^a   Dai, Yong ^a   Peng, Wujian ^a   Lu, Juanjuan ^b   Zhang, Yanliang ^a   Wang, Linxian ^a  

^a JINAN UNIVERSITY   (China)

^b SHANTOU UNIVERSITY   (China)

Author keywords

Chromatin immunoprecipitation; Histone H3 lysine 4; Microarray; Minimal change nephrotic syndrome; Trimethylation

Indexed keywords

HISTONE H3; HISTONE H3 LYSINE 4; MESSENGER RNA; UNCLASSIFIED DRUG; HISTONE; LYSINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; MALE; MICROARRAY ANALYSIS; MINIMAL CHANGE NEPHROTIC SYNDROME; NEPHROTIC SYNDROME; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRIMETHYLATION; AGED; CPG ISLAND; DNA MICROARRAY; GENETIC ASSOCIATION; GENETIC EPIGENESIS; GENETICS; LIPOID NEPHROSIS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PHYSIOLOGY;

AGED; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HISTONES; HUMANS; LEUKOCYTES, MONONUCLEAR; LYSINE; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 70349600770     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000243811     Document Type: Article

References (50)

1. Minimal change nephrotic syndrome in children: deaths during the first 5 to 15 years' observation. Report of the International Study of Kidney Disease in Children. Pediatrics 1984; 73: 497-501.
2. Coggis CH: Minimal change nephrosis in adults; in Zurukzoglu W (ed): Treatable and Preventable Glomerular Disease, Proceedings of the 8th International Congress of Nephrology. Basel, Karger, 1981, pp 336-344.
3. Lewis EJ: Management of the nephrotic syndrome in adults; in Caeron JS, Glassock RJ (eds): The Nephrotic Syndrome. New York, Dekker, 1988, pp 461-521.
4. Cho MH, Hong EH, Lee TH, Ko CW: Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Nephrology (Carlton) 2007; 12 (suppl 3):S11-S14.
5. van den Berg JG, Weening JJ: Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome. Clin Sci (Lond) 2004; 107: 125-136.
6. Laflam PF, Garin EH: Effect of tumor necrosis factor alpha and vascular permeability growth factor on albuminuria in rats. Pediatr Nephrol 2006; 21: 177-181.
7. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M: A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 1991; 40: 453-460.
8. Tanaka R, Yoshikawa N, Nakamura H, Ito H: Infusion of peripheral blood mononuclear cell products from nephrotic children increases albuminuria in rats. Nephron 1992; 60: 35-41.
9. Araya CE, Wasserfall CH, Brusko TM, Mu W, Segal MS, Johnson RJ, Garin EH: A case of unfulfilled expectations: cytokines in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 2006; 21: 603-610.
10. Laflam PF, Haraguchi S, Garin EH: Cytokine mRNA profile in lipoid nephrosis: evidence for increased IL-8 mRNA stability. Nephron 2002; 91: 620-626.
11. Neuhaus TJ, Wadhwa M, Callard R, Barratt TM: Increased IL-2, IL-4 and interferongamma (IFN-gamma) in steroid-sensitive nephrotic syndrome. Clin Exp Immunol 1995; 100: 475-479.
12. Lachner M., Jenuwein T: The many faces of histone lysine methylation. Curr Opin Cell Biol 2002; 14: 286-298.
13. Martin C, Zhang Y: The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 2005; 6: 838-849.
14. Ruthenburg AJ, Allis CD, Wysocka J: Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 2007; 25: 15-30.
15. Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NC, Schreiber SL, Mellor J, Kouzarides T: Active genes are tri-methylated at K4 of histone H3. Nature 2002; 419: 407-411.
16. Schneider R, Bannister AJ, Myers FA, Thorne AW, Crane-Robinson C, Kouzarides T: Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nature Cell Biol 2004; 6: 73-77.
17. Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, Huebert DJ, McMahon S, Karlsson EK, Kulbokas EJ 3rd, Gingeras TR, Schreiber SL, Lander ES: Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 2005; 120: 169-181.
18. Bannister AJ, Kouzarides T: Histone methylation: recognizing the methyl mark. Methods Enzymol 2004; 376: 269-288.
19. Fraga MF, Ballestar E, Villar-Garea A, et al: Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 2005; 37: 391-400.
20. Wu J, Smith LT, Plass C, Huang TH: ChIPchip comes of age for genome-wide functional analysis. Cancer Res 2006; 66: 6899-6902.
21. Wu J, Wang SH, Potter D, Liu JC, Smith LT, Wu YZ, Huang TH, Plass C: Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing. BMC Genomics 2007; 8: 131.
22. O'Geen H, Squazzo SL, Iyengar S, Blahnik K, Rinn JL, Chang HY, Green R, Farnham PJ: Genome-wide analysis of KAP1 binding suggests autoregulation of KRAB-ZNFs. PLoS Genet 2007; 3:e89.
23. Opel M, Lando D, Bonilla C, Trewick SC, Boukaba A, Walfridsson J, Trewick SC, Cauwood J, Werler PJ, Carr AM, Kouzarides T, Murzina NV, Allshire RC, Ekwall K, Laue ED: Genome-wide studies of histone demethylation catalysed by the fission yeast homologues of mammalian LSD1. PLoS ONE 2007; 2:e386.
24. Ren B, Robert F, Wyrick JJ, Aparicio O, Jennings EG, Simon I, Zeitlinger J, Schreiber J, Hannett N, Kanin E, Volkert TL, Wilson CJ, Bell SP, Young RA: Genome-wide location and function of DNA binding proteins. Science 2000; 290: 2306-2309.
25. Weinmann AS, Yan PS, Oberley MJ, Huang TH, Farnham PJ: Isolating human transcription factor targets coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev 2002; 16: 235-244.
26. Miao F, Wu X, Zhang L, Yuan YC, Riggs AD, Natarajan R: Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes. J Biol Chem 2007; 282: 13854-13863.
27. Zhang L, Zhong K, Dai Y, Zhou H: Genomewide analysis of histone H3 lysine 27 trimethylation by ChIP-chip in gastric cancer patients. J Gastroenterol 2009;44: 305-312.
28. Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, Yamochi T, Urano T, Furukawa K, Kwabi-Addo B, Gold DL, Sekido Y, Huang TH, Issa JP: Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 2008; 40: 741-750.
29. Huebert DJ, Kamal M, O'Donovan A, Bernstein BE: Genome-wide analysis of histone modifications by ChIP-on-chip. Methods 2006; 40: 365-369.
30. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.
31. Jenuwein T, Allis CD: Translating the histone code. Science 2001; 293: 1074-1080.
32. Roh TY, Cuddapah S, Cui K, Zhao K: The genomic landscape of histone modifications in human T cells. Proc Natl Acad Sci USA 2006; 103: 15782-15787.
33. Liang G, Lin JC, Wei V, Yoo C, Cheng JC, Nguyen CT, Weisenberger DJ, Egger G, Takai D, Gonzales FA, Jones PA: Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. Proc Natl Acad Sci USA 2004; 101: 7357-7362.
34. Heisler LE, Torti D, Boutros PC, Watson J, Chan C, Winegarden N, Takahashi M, Yau P, Huang TH, Farnham PJ, Jurisica I, Woodgett JR, Bremner R, Penn LZ, Der SD: CpG island microarray probe sequences derived from a physical library are representative of CpG islands annotated on the human genome. Nucleic Acids Res 2005; 33: 2952-2961.
35. Izuhara K: Atopy and interleukin-4 receptor (in Japanese). Rinsho Byori 1999; 47: 525-530.
36. Andrews AL, Holloway JW, Holgate ST, Davies DE: IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets. J Immunol 2006; 176: 7456-7461.
37. Lai KW, Wei CL, Tan LK, Tan PH, Chiang GS, Lee CG, Jordan SC, Yap HK: Overexpression of interleukin-13 induces minimalchange- like nephropathy in rats. J Am Soc Nephrol 2007; 18: 1476-1485.
38. Oukka M, Wein MN, Glimcher LH. Schnurri- 3 (KRC) interacts with c-Jun to regulate the IL-2 gene in T cells. J Exp Med 2004; 199: 15-24.
39. Leppä S, Bohmann D: Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene 1999; 18: 6158-6162.
40. Ghosh S, May MJ, Kopp EB: NF-kappaB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 226-260.
41. Irie A, Harada K, Tsukamoto H, Kim JR, Araki N, Nishimura Y: Protein kinase D2 contributes to either IL-2 promoter regulation or induction of cell death upon TCR stimulation depending on its activity in Jurkat cells. Int Immunol 2006; 18: 1737-1747.
42. Hao Q, Wang L, Zhao ZJ, Tang H: Identification of protein kinase D2 as a pivotal regulator of endothelial cell proliferation, migration, and angiogenesis. J Biol Chem 2009; 284: 799-806.
43. D'Souza SS, Fazleabas AT, Banerjee P, Sherwin JR, Sharkey AM, Farach-Carson MC, Carson DD: Decidual heparanase activity is increased during pregnancy in the baboon (Papio anubis) and in in vitro decidualization of human stromal cells. Biol Reprod 2008; 78: 316-323.
44. Jin Z, Cheng Y, Olaru A, Kan T, Yang J, Paun B, Ito T, Hamilton JP, David S, Agarwal R, Selaru FM, Sato F, Abraham JM, Beer DG, Mori Y, Shimada Y, Meltzer SJ: Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors. Int J Cancer 2008; 123: 2331-2336.
45. Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF: Loss of expression and aberrant methylation of the CDH13 (Hcadherin) gene in breast and lung carcinomas. Cancer Res 2001;61: 4556-4560. (Pubitemid 32685789)
46. Kim DS, Kim MJ, Lee JY, Kim YZ, Kim EJ, Park JY: Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features. Cancer 2007; 110: 2785-2792.
47. Delcuve GP, Rastegar M, Davie JR: Epigenetic control. J Cell Physiol 2009; 219: 243-250.
48. Law JA, Jacobsen SE: Molecular biology: dynamic DNA methylation. Science 2009; 323: 1568-1569.
49. Irvine RA, Lin IG, Hsieh CL: DNA methylation has a local effect on transcription and histone acetylation. Mol Cell Biol 2002; 22: 6689-6696.
50. Okitsu CY, Hsieh CL: DNA methylation dictates histone H3K4 methylation. Mol Cell Biol 2007; 27: 2746-2757.